Exagen Raises $5.3M For Diagnostic Tests

Albuquerque, New Mexico-baesd Exagen Diagnostics, which develops diagnostic testing for rheumatoid arthritis and other conditions, has raised $5.3M in a funding round. The round was led by Tullis Health Investors, and also included Sun Mountain Capital, Cottonwood Technology Fund, Mesa Verde Venture Partners and Epic Ventures. The firm said it will use the funding to finance market expansion and develop its near-term pipeline. More information »